Progress in knowledge of c-Src in tumour genesis has resulted in Src kinase inhibition being investigated as a therapeutic target for anti-invasive therapies in breast cancer (Rucci et al, 2006; Finn et al, 2007). Here, SRC is linked to neoplasm.